Category Archives: Uncategorized
Launch of Co-Exforge – Novartis South Africa has launched Co-Exforge® effective from 23 October 2012.
It includes:
Co-Exforge® 5 mg/160 mg/12,5 mg
Co-Exforge® 5 mg/160 mg/25 mg
Co-Exforge® 10 mg/160 mg/12,5 mg
Co-Exforge® 10 mg/160 mg/25 mg
For any queries please contact the Novartis Customer Support Line on 0861 929 929
The South African Pharmacy Council is hosting the 1st Conference ever for pharmacy on 23 – 26 June 2013 in Sun City, North West Province, South Africa. This conference earmarks to bring all pharmacy professionals and friends of the profession to this prestigious event to share challenges and developments both nationally and internationally, to tackle debate and attempt to resolve issues that are common to all in pharmacy. The conference should provide ‘an opportunity to find and strengthen that which is supposed to constitute the bond, the common thread that transcends all sectoral affiliations, as we seek to move as one in a direction that can only benefit those that we claim to serve unselfishly’ says the President of Council, Mr Bada Pharasi. Issues that touch the nerve of pharmacy, the service delivery and policy issues will be the centre of focus. Please ensure that you are part of this historical moment by supporting the course for pharmacy.
www.sapcconference.za.org
Taking nonsteroidal anti-inflammatory drugs (NSAIDs) appears to significantly lower the risk for developing several major forms of skin cancer, a new Danish study reveals.
What’s more, the apparent protective impact of both prescription and nonprescription NSAIDs on skin cancer risk seems to be stronger the longer someone takes them.
http://www.drugs.com/news/common-painkillers-may-help-prevent-skin-cancer-study-38435.html
A team of scientists at McMaster University has discovered a drug, thioridazine, successfully kills cancer stem cells in the human while avoiding the toxic side-effects of conventional cancer treatments.
Thioridazine works through the dopamine receptor on the surface of the cancer cells in both leukemia and breast cancer patients. This means it may be possible to use it as a biomarker that would allow early detection and treatment of breast cancer and early signs of leukemia progression.